M. Jorgensen

First name
M.
Middle name
E.
Last name
Jorgensen
Kosiborod, M., Cavender, M. A., Fu, A. Z., Wilding, J. P., Khunti, K., Holl, R. W., et al. (2017). Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotranspo. Circulation. http://doi.org/10.1161/circulationaha.117.029190
Venkatesan, S., Myles, P. R., Manning, H. J., Mozid, A. M., Andersson, C., Jorgensen, M. E., et al. (2017). Cohort study of preoperative blood pressure and risk of 30-day mortality after elective non-cardiac surgery. Br J Anaesth. http://doi.org/10.1093/bja/aex056
Cavender, M. A., Norhammar, A., Birkeland, K. I., Jorgensen, M. E., Wilding, J. P., Khunti, K., et al. (2018). SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL. J Am Coll Cardiol. http://doi.org/10.1016/j.jacc.2018.01.085
Venkatesan, S., Jorgensen, M. E., Manning, H. J., Andersson, C., Mozid, A. M., Coburn, M., et al. (2019). Preoperative chronic beta-blocker prescription in elderly patients as a risk factor for postoperative mortality stratified by preoperative blood pressure: a cohort study. Br J Anaesth. http://doi.org/10.1016/j.bja.2019.03.042